Clinical Trial

An AI-Based Erythema Measurement System for Psoriasis Lesions

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Psoriasis is a common chronic inflammatory skin disease. Disease severity is commonly assessed using the Psoriasis Area and Severity Index (PASI), in which erythema is graded subjectively on a 0-4 scale. This visual assessment is prone to significant inter- and intra-rater variability. Although objective tools such as colorimeters provide accurate erythema measurement, their high cost limits routine clinical use. Smartphone imaging combined with artificial intelligence (AI) offers a practical alternative for objective assessment. However, variability in lighting conditions can affect image consistency. Incorporating a color calibration card enables accurate color normalization. This study aims to develop and validate an AI-based system for measuring erythema in psoriatic lesions using smartphone images with a color card, compared against a standard colorimeter to assess validity and reliability.
Trial Details
NCT Number NCT07494396
Lead Sponsor Khon Kaen University
Conditions Psoriasis
Enrollment 50 participants
Start Date 2026-11-01
Primary Completion 2027-04-20 (estimated)
Study Completion 2027-04-20 (estimated)
Updated on ClinicalTrials.gov 2026-08-05